Bipolar disorder is among the most complex and consequential psychiatric conditions clinicians encounter. Its treatment requires coordination across multiple domains — pharmacological, psychosocial, and lifestyle — and the psychotherapy evidence base, while growing, points clearly toward structured, evidence-based adjunctive interventions as complements to medication rather than replacements for it. Gestalt therapy is not a first-line treatment for bipolar disorder. What it may offer, within a well-coordinated treatment context, is an experiential, phenomenological, and relational framework that addresses dimensions of living with bipolar disorder — self-awareness, emotional contact, relational patterns, and embodied experience — that structured protocols do not always reach. This article examines what the evidence actually shows, what Gestalt therapy can and cannot offer, and how clinicians working with bipolar disorder might think clearly about where experiential approaches fit.
GestaltReview.com · Clinical Applications · Evidence-Informed Practice
Gestalt Therapy and Bipolar Disorder Awareness, Relationships, and the Current Evidence
What bipolar disorder is, what the evidence-based treatment landscape looks like, what Gestalt therapy can and cannot offer, and how practitioners can think clearly about where experiential psychotherapy fits within responsible clinical care.
Important Clinical Notice
Bipolar disorder is a serious psychiatric condition that typically requires multidisciplinary treatment including psychiatric assessment and, for many people, medication. This article is for educational purposes. It does not constitute clinical guidance. Individuals with or suspected of having bipolar disorder should seek assessment from a qualified psychiatrist or mental health professional. Gestalt therapy, or any psychotherapy, should not be pursued as a substitute for appropriate psychiatric care when indicated.
Introduction
Bipolar disorder affects approximately 2–4% of the population across all countries, cultures, and demographic groups studied. It is associated with substantial functional impairment, elevated suicide risk — with lifetime rates of suicidal behaviour significantly higher than in the general population — and a chronicity that requires sustained, multi-level clinical attention rather than episodic crisis management. Despite advances in pharmacological treatment, a significant proportion of people with bipolar disorder continue to experience mood episodes on medication, and functional impairment between episodes remains substantial for many.
This clinical picture has driven sustained research into adjunctive psychosocial interventions — treatments that work alongside rather than instead of medication, addressing the dimensions of bipolar disorder that pharmacotherapy alone cannot reach: emotional processing, relational functioning, lifestyle regularity, early warning sign recognition, medication adherence, and the profound psychosocial challenges of living with a condition that affects identity, relationships, and capacity for self-regulation in complex and often unpredictable ways.
Gestalt therapy's contribution to this landscape is necessarily modest in evidential terms: there are no randomised controlled trials specifically examining Gestalt therapy for bipolar disorder, and direct evidence claims would be unsupportable. What Gestalt therapy offers is a theoretical framework and a set of clinical capacities — awareness cultivation, phenomenological inquiry, embodied contact, and genuine dialogical presence — that are relevant to the lived experience of bipolar disorder and that may complement evidence-based approaches in specific clinical contexts. This article examines both what the evidence shows and what Gestalt therapy can reasonably offer within a responsible clinical framework.
What Is Bipolar Disorder?
Bipolar disorder is a chronic, episodic mood disorder characterised by recurrent episodes of abnormally elevated or irritable mood (mania or hypomania) and, in most presentations, episodes of major depression. Between episodes, functioning may be substantially recovered — or may remain impaired by subsyndromal symptoms, cognitive difficulties, or the cumulative functional impact of previous episodes. The disorder is defined by the occurrence of elevated mood states; depression, while predominant in terms of lifetime episode burden and functional impact, is not sufficient to establish the diagnosis.
The heterogeneity of bipolar disorder presentations — across subtypes, across individuals, and across the lifespan within the same individual — is clinically significant. No two people with bipolar disorder experience the condition in exactly the same way, and effective clinical work requires attention to the specific phenomenology of this person's condition rather than generic bipolar disorder management. This is, notably, precisely what the phenomenological orientation of Gestalt therapy is equipped to provide.
Diagnostic Features and Subtypes
Bipolar I Disorder
Defined by the occurrence of at least one manic episode — a distinct period of abnormally elevated, expansive, or irritable mood lasting at least 7 days, accompanied by at least three additional symptoms (grandiosity, decreased sleep need, pressured speech, racing thoughts, distractibility, increased goal-directed activity, or reckless behaviour) that cause marked functional impairment or require hospitalisation. Depressive episodes are common but not required for the diagnosis. The manic episode may include psychotic features. Bipolar I carries the highest risk of hospitalisation and the most severe acute presentations.
Bipolar II Disorder
Defined by at least one hypomanic episode and at least one major depressive episode, without a full manic episode. Hypomania shares the same symptom criteria as mania but is less severe, shorter in duration (at least 4 days), and does not cause marked functional impairment or require hospitalisation. Bipolar II is often misdiagnosed as unipolar depression, delaying appropriate treatment. The depressive burden in Bipolar II is typically greater than in Bipolar I — people with Bipolar II often spend a higher proportion of time in depressive states, making depression the primary clinical challenge for many.
Cyclothymic Disorder
Characterised by numerous periods of hypomanic symptoms and depressive symptoms over at least two years (one year in children), neither of which meet full diagnostic criteria for a hypomanic episode or major depressive episode. Symptoms are persistent, rarely free of mood instability for more than two months at a time. Cyclothymia is often experienced as a trait-like pattern of emotional dysregulation rather than discrete episodes, and may be underdiagnosed. It carries a risk of progressing to Bipolar I or II disorder.
Additional specifiers in the DSM-5-TR include mixed features (the concurrent presence of depressive symptoms during elevated episodes or vice versa), rapid cycling (four or more mood episodes per year), peripartum onset, and seasonal pattern. These specifiers significantly affect prognosis, treatment response, and clinical approach. Clinicians working with people with bipolar disorder need to understand which subtype and which specifiers characterise the specific presentation they are working with.
Causes, Risk Factors, and Course
Bipolar disorder has a substantial genetic component — heritability estimates from twin studies range from 60–80% — but the genetic architecture is complex, involving multiple genes of small effect rather than a single determinative mutation. Environmental factors, including early childhood adversity, sleep disruption, substance use, stressful life events, and social rhythm irregularity, interact with genetic predisposition to shape onset, course, and severity. The disorder typically first manifests in late adolescence or early adulthood, though onset can occur across the lifespan.
Without effective treatment, the natural course of bipolar disorder is one of recurrence: most untreated individuals will experience multiple episodes over their lifetime, with evidence suggesting that episodes may kindle additional episodes (the "kindling hypothesis") — earlier interventions and sustained prophylactic treatment are associated with better long-term outcomes than delayed treatment. Functional impairment between episodes — in social and occupational domains, in cognitive functioning, and in wellbeing — is common and often underaddressed by symptom-focused approaches alone. Scott and colleagues (2007) specifically noted that adjunctive psychotherapy is significantly less effective for patients with a high number of prior episodes (more than 12), underlining the importance of early and sustained intervention.
Current Evidence-Based Treatment
Medication
Pharmacological treatment is the cornerstone of bipolar disorder management according to all major international clinical guidelines — NICE (UK), APA (USA), CANMAT (Canada), and BAP (British). Mood stabilisers (lithium, valproate, lamotrigine) and atypical antipsychotics form the primary pharmacological armamentarium, with specific agents having different evidence profiles for acute mania, acute bipolar depression, and maintenance prophylaxis. Medication adherence is a significant clinical challenge: nonadherence is common, strongly associated with relapse, and multi-factorial in its causes — involving side effects, insight, beliefs about medication, and the interpersonal dynamics of the treatment relationship.
Psychotherapy in the Evidence Base
The psychosocial treatments with the strongest evidence base in bipolar disorder are: group and family psychoeducation, cognitive-behavioural therapy (CBT), interpersonal and social rhythm therapy (IPSRT), and family-focused therapy (FFT). Each has specific evidence strengths and limitations. These are reviewed in Section 6 and compared with Gestalt therapy in Section 15.
Lifestyle and Relapse Prevention
Sleep regularity, circadian rhythm stability, reduction of substance use, stress management, and early warning sign recognition are consistently identified in both clinical guidelines and psychosocial treatment research as key modifiable risk factors for relapse. The Social Rhythm Metric — a core tool in IPSRT — operationalises this insight, providing a structured way to monitor and stabilise daily activity patterns that influence circadian rhythms and thereby mood stability. Any psychotherapeutic approach working with people with bipolar disorder needs to attend to these lifestyle dimensions, either directly or through appropriate coordination with other elements of the person's treatment.
The Psychotherapy Evidence Base
Key Research — Adjunctive Psychotherapy for Bipolar Disorder
Miklowitz and colleagues' (2020) network meta-analysis — the most comprehensive quantitative synthesis to date, covering 39 RCTs and 3,863 participants — found that adjunctive psychotherapy was associated with significantly lower recurrence rates than control treatments (OR 0.56; 95% CI 0.43–0.74). Critically, the meta-analysis identified moderation of treatment form: psychoeducation with guided practice of illness management skills was dramatically more effective in group or family format (OR 0.12) than in individual format for preventing recurrences. CBT showed a moderate effect on depressive symptoms (SMD −0.32; 95% CI −0.64 to −0.01). Family or conjoint therapy showed stronger treatment retention. The authors explicitly noted heterogeneity in populations, treatment duration, and follow-up as limiting factors.
Oud and colleagues' (2016) systematic review and meta-analysis of 55 trials (6,010 participants) found moderate-quality evidence associating individual psychological interventions with reduced relapses both post-treatment (RR 0.66) and at follow-up (RR 0.74), with collaborative care reducing hospital admissions. Much of the evidence was rated low to very low quality, limiting firm conclusions.
Scott and colleagues' (2007) earlier meta-analysis of 8 RCTs demonstrated approximately 40% reduction in relapse rates with adjunctive psychological therapies. Crucially, they identified an important moderator: therapies were most effective for patients who were euthymic (mood-stable) when recruited, and less effective for those with more than 12 prior episodes — a finding with direct clinical implications for how and when psychotherapy should be offered.
Yilmaz and colleagues (2025) individual patient data meta-analysis of 6 studies (668 participants) found that psychological interventions significantly reduced bipolar depression scores overall, with CBT specifically showing reduction versus comparator conditions. There was no evidence of moderation by baseline depression severity.
Mindfulness-based interventions: Chu and colleagues' (2017) meta-analysis found significant within-group reductions in depression (g = 0.58) and anxiety (g = 0.34) but no significant effect in controlled comparisons — a finding that requires honest acknowledgement: within-group pre-post changes are a weaker form of evidence than controlled comparisons, and the controlled evidence for mindfulness in bipolar disorder remains preliminary.
Where Does Gestalt Therapy Fit?
Gestalt therapy is not listed in any major international clinical guidelines as an evidence-based treatment for bipolar disorder, because no randomised controlled trials of Gestalt therapy specifically for bipolar disorder have been conducted and published. This must be stated clearly at the outset: the evidence for Gestalt therapy in bipolar disorder is indirect, theoretical, and clinical rather than empirically established in the specific sense that the psychotherapy research literature requires. Clinicians who work with people with bipolar disorder within a Gestalt framework are doing so on the basis of clinical judgment and theoretical congruence, not on the basis of trial evidence.
What Gestalt therapy may offer, within an appropriate treatment context that includes psychiatric care when indicated, is a phenomenological, experiential, and relational approach to the dimensions of bipolar disorder that structured, skill-based interventions are not primarily designed to address. These include: the cultivation of present-moment awareness that may support early warning sign recognition; the embodied attunement that may help individuals track somatic signals of impending mood shifts; the relational contact work that may address the interpersonal injuries and withdrawal patterns associated with mood episodes; and the phenomenological attention to the specific quality of this person's lived experience of bipolar disorder rather than generic disorder management.
The key clinical caveat bears repeating: Gestalt therapy should be understood as a potential complement to, not a substitute for, the evidence-based treatment components that the research supports for bipolar disorder. For most people with Bipolar I disorder or significant Bipolar II presentations, this includes pharmacological treatment under psychiatric supervision. Any Gestalt therapist working with a client with bipolar disorder should maintain appropriate liaison with the client's psychiatric care team, understand the psychiatric dimensions of the condition, and be aware of the clinical warning signs that require urgent psychiatric attention. For the general overview of how Gestalt therapy is applied across clinical presentations, see our article on Applications of Gestalt Therapy.
Awareness and Mood Monitoring
One of the most consistently identified active components of effective psychosocial treatment for bipolar disorder is early warning sign recognition — the capacity to notice the early signs of impending mood episodes and to activate appropriate responses before the episode escalates to a point at which autonomous self-management is compromised. This requires a specific quality of self-awareness: not retrospective analysis of past episodes, but a practised, present-moment attentiveness to one's own internal states, somatic signals, and early behavioural changes.
This is precisely the clinical territory that Gestalt therapy's foundational concept of awareness is designed to cultivate. The Gestalt understanding of awareness as a present-moment, embodied, phenomenologically disciplined attending to one's own experience — not merely cognitive understanding of it — is directly relevant to what early warning sign recognition actually requires. The person who has learned, through sustained therapeutic work, to notice when their internal experience has a quality of accelerating pressure, when the texture of sleep has changed, when their relationship to others has shifted in quality, is more likely to recognise the early signs of a hypomanic or manic episode than the person who must wait for the episode to be fully established before they recognise what is happening.
A client with Bipolar II disorder has learned through sustained therapy to track what she calls the "too-alive feeling" — a quality of slightly accelerated internal tempo, increased sensory vividness, and a subtle reduction in the felt need for sleep, that typically precedes a hypomanic episode by several days. In Gestalt terms, she is tracking a somatic sensation-level signal before it has escalated into full hypomanic awareness and mobilisation. The therapeutic work that made this tracking possible involved not teaching her a list of early warning signs but cultivating, over months of present-moment phenomenological attention in sessions, a more sensitive and more precise relationship to her own somatic and affective experience. When she notices the "too-alive feeling," she can now engage her agreed response protocol — contacting her psychiatrist, reducing stimulation, prioritising sleep — before the episode requires more intensive intervention.
This kind of present-moment somatic awareness does not require that the therapist be conducting formal bipolar disorder psychoeducation. It emerges from the sustained cultivation of genuine phenomenological attention within the therapeutic encounter — the same therapeutic work that Gestalt therapy conducts across presentations. For the foundational account, see our article on Here and Now in Gestalt Therapy.
Embodiment and Somatic Tracking
The body is a primary signal system in bipolar disorder. Changes in sleep architecture — both reduced sleep need in hypomania and hypersomnia or insomnia in depression — are among the most reliable early indicators of mood state changes, and often precede other observable signs. Changes in somatic energy, in the felt quality of appetite and physical drive, in the rhythm and quality of movement and speech — all of these carry information about mood state that becomes clinically available only if the person has developed sufficient somatic attentiveness to receive it.
Gestalt therapy's emphasis on embodied awareness — on attending to the body's signals as primary data about the organism's current state rather than as incidental accompaniments to the "real" psychological work — is directly relevant here. The therapist who attends to the quality of a client's energy in the room, to changes in their somatic presentation across sessions, to the texture of their physical engagement with the therapeutic encounter, may notice early signs of mood state change that the client has not yet consciously registered. This is not a substitute for formal clinical monitoring or for the client's own practice of mood monitoring outside sessions, but it is a genuine clinical contribution that embodied attentiveness makes possible.
The circadian rhythm research underlying IPSRT is also relevant here. Social rhythm irregularity — disruptions to the regular daily patterns of activity that entrain circadian rhythms — is a significant precipitant of mood episodes in bipolar disorder. Gestalt therapy's attention to the quality of the organism's present-moment somatic experience can complement the more structured rhythm-monitoring of IPSRT by bringing phenomenological depth to what might otherwise remain a behavioural charting exercise. For the full account, see our article on Embodied Awareness and the Body in Gestalt Therapy.
Contact, Relationships, and Interpersonal Functioning
Bipolar disorder is profoundly interpersonal in its consequences. Mood episodes — particularly manic and mixed episodes — can cause significant relational harm: damaged relationships, broken commitments, actions and communications that the person later regrets and that their relationships must somehow process. The aftermath of an episode often involves interpersonal repair work, shame, grief for the relational damage caused, and the complex task of rebuilding trust with significant others. Depressive episodes bring a different interpersonal challenge: withdrawal, the difficulty of genuine contact from within the depressive experience, and the strain that chronic low mood places on intimate relationships.
Gestalt therapy's contact framework — its understanding of the patterns through which genuine relational engagement is approached and avoided, and of the conditions under which genuine dialogical meeting becomes possible — is directly applicable to this interpersonal territory. The contact disturbances that Gestalt therapy identifies (retroflection, deflection, confluence, introjection, projection) may be particularly prominent in the interpersonal functioning of people with bipolar disorder: the shame-driven withdrawal of the post-episode period, the hyper-vigilant monitoring of others' reactions, the protective distancing that may have developed from repeated experiences of relational harm associated with mood episodes.
For a fuller account of how the contact framework operates, see our articles on Contact and Withdrawal in Gestalt Therapy and Gestalt Therapy and Attachment Theory.
Emotion Regulation and the Gestalt Framework
Emotion dysregulation is a core feature of bipolar disorder — not only during acute episodes but, for many people, as a more persistent inter-episode pattern that includes emotional reactivity, difficulty with frustration tolerance, and challenges in down-regulating intense affective states. The Gestalt cycle of experience provides a theoretical account of how emotion regulation difficulties arise: when the natural cycle from sensation to awareness to contact to satisfaction is interrupted at characteristic points, the organism's capacity for self-regulation is compromised.
What Gestalt therapy offers in this domain is not a structured emotion regulation protocol of the kind that Dialectical Behaviour Therapy provides, and clinicians should be clear about this distinction. DBT's evidence base for emotion regulation specifically in BPD presentations that overlap with bipolar disorder features is established; Gestalt therapy's evidence for emotion regulation in bipolar disorder is not. What Gestalt therapy offers instead is an experiential approach to developing the organism's awareness of and relationship to its own affective experience — which may, over time, support greater regulatory capacity through the same mechanisms that the interoception and experiencing research suggest underlie emotion regulation more broadly.
Larcipretti and colleagues' (2025) systematic review of DBT for bipolar disorder found beneficial effects on mood episodes among adolescents and adults, supporting its use alongside pharmacotherapy. Gestalt therapists working with people who have significant emotion regulation difficulties alongside bipolar disorder should be familiar with this evidence and may appropriately consider referring for or collaborating with more structured skills-based approaches where indicated. For the full theoretical account, see our article on The Gestalt Cycle of Experience.
Working During Depressive Episodes
Bipolar depression is the dominant mood state in terms of lifetime episode burden for most people with bipolar disorder, and it carries specific clinical challenges distinct from unipolar depression. The presence of psychomotor retardation, profound fatigue, cognitive slowing, and severe anhedonia — all of which reduce the availability of the energy and the cognitive resources that experiential therapeutic work typically requires — shapes what is possible in Gestalt clinical work during depressive episodes.
During acute depressive episodes, the pace and intensity of Gestalt therapeutic work needs significant modulation. The phenomenological inquiry that characterises Gestalt practice — which invites the client toward present-moment, embodied contact with their experience — may feel unbearable during periods of severe depression when the present-moment experience is one of profound suffering with no relief visible. The therapist's presence — calm, attuned, genuinely accompanying — may be more clinically significant than any specific therapeutic intervention during the darkest periods of a bipolar depressive episode.
What Gestalt therapy can offer during depressive episodes, specifically, is phenomenological companionship: the genuine willingness to be present to the person's actual experience without rushing them toward a state that feels more tolerable to the therapist, and without abandoning the genuine contact that Gestalt therapy's dialogical stance requires. This is not passive; it is an active, sustained, relationally engaged presence within the experience of depression rather than alongside it. For the relevant account of how Gestalt approaches trauma and extreme psychological states, see our article on Gestalt Therapy and Trauma.
Clinicians must also be alert to suicidal ideation and risk during depressive episodes. Bipolar disorder is associated with significantly elevated lifetime suicide risk, and this risk is highest during depressive and mixed episodes. Appropriate risk assessment, safety planning, and liaison with psychiatric services when needed are non-negotiable clinical responsibilities that supersede any therapeutic framework.
Clinical Considerations During Mania and Hypomania
Clinical work during manic and hypomanic episodes requires a substantially different orientation from work during depressive or euthymic periods. During full mania, individual outpatient psychotherapy is typically not the appropriate primary clinical intervention — hospitalisation may be required, and the acute priorities of safety and mood stabilisation take precedence over therapeutic exploration. Clinicians who attempt to conduct Gestalt-style experiential work with a client in acute mania are likely to find that the elevated arousal, disinhibition, reduced need for sleep, and altered reality testing that characterise the manic state prevent the kind of grounded, present-moment phenomenological attention that Gestalt therapy requires.
During hypomania — which by definition involves less severe elevation, without psychotic features and without the severe functional impairment of mania — the clinical picture is more complex. The hypomanic state often feels genuinely positive to the person experiencing it: increased energy, reduced need for sleep, heightened creativity, and a quality of aliveness and expanded possibility that contrasts sharply with the depressive states that preceded or will follow it. This creates a specific clinical challenge: the person may be ambivalent about interventions that interrupt or reduce the hypomanic state, and may have a complex relationship to the identity implications of acknowledging that their current elevated state is part of a disorder rather than their "true self."
Clinical Cautions — Elevated Mood States
Avoid deep experiential exploration during mania. The elevated arousal, boundary loosening, and reduced reality testing of acute mania are contraindications for intensive experiential work that invites further expansion of emotional expression or boundary dissolution. Priority: safety, liaison with psychiatric team, supportive containment.
Hypomania requires careful pacing. The heightened energy and apparent insight of hypomania can be mistaken for therapeutic progress. Clinicians should monitor carefully for escalation, maintain the therapeutic frame, and be prepared to modify the work significantly if elevation progresses.
Grief for the lost hypomanic self. A significant therapeutic task that emerges once mood stability is achieved is the grief for what is lost when the hypomanic state resolves — the energy, the creativity, the aliveness. IPSRT specifically identifies this as "grief for the lost healthy self"; Gestalt therapy's framework of genuine present-moment contact with grief and loss is directly relevant. Acknowledging and working with this ambivalence, rather than simply congratulating the person on their mood stabilisation, is clinically important.
Medication and therapeutic alliance. Resistance to medication is common in bipolar disorder, particularly in relation to the hypomanic states that many people experience as positive. The therapeutic relationship may be a crucial vehicle for supporting a more nuanced, informed, and personally meaningful relationship to medication — not through persuasion but through genuine exploration of the person's actual experience of both their illness and its treatment.
The Therapeutic Relationship
The therapeutic relationship is among the most consistent predictors of positive outcome across psychotherapy research, and this holds in bipolar disorder treatment as in other contexts. Miklowitz (2008), in his review of 18 randomised trials, identified treatment retention and the therapeutic relationship as significant mediators of outcome across modalities — approaches that maintained stronger therapeutic alliances showed better retention and better outcomes.
Gestalt therapy's dialogical, genuinely relational approach — its understanding of the therapeutic relationship as the primary medium of change rather than a container for technique — may offer specific advantages in this domain for people with bipolar disorder. The chronic, recurrent nature of the condition, and the relational strain that mood episodes often produce, may mean that some people with bipolar disorder have a complex and often troubled relationship to help-seeking: they may have experienced multiple therapeutic relationships that dissolved at points of crisis, or that felt transactional rather than genuinely engaged. The quality of genuine I-Thou meeting that Gestalt therapy's dialogical philosophy requires — the therapist's genuine presence, genuine responsiveness, and genuine willingness to remain engaged across the full range of mood states — may provide something of specific value for this population.
The consistency of the therapeutic relationship across mood states — the therapist who is genuinely present during the depressive withdrawal, during the hypomanic expansion, and during the euthymic periods of relative stability, and who maintains a consistent, warm, non-reactive presence through all of these — is itself a stabilising relational experience that may complement the more structured stabilisation that IPSRT's social rhythm work and psychoeducation's illness management focus provide.
Comparing Gestalt with Evidence-Based Modalities
| Modality | Primary Evidence Strength | Core Mechanism | Relationship to Gestalt Therapy |
|---|---|---|---|
| Psychoeducation (group/family) | Strong for relapse prevention, especially in group/family format (OR 0.12 in Miklowitz et al., 2020). Best evidence for early-stage, euthymic patients | Knowledge of illness, early warning sign recognition, medication adherence, lifestyle management | Gestalt therapy does not provide psychoeducation but its awareness cultivation may deepen the application of psychoeducational knowledge |
| CBT | Moderate evidence for depression reduction (g = −0.494) and relapse prevention (OR 0.506). Most effective when euthymic at entry | Cognitive restructuring, behavioural activation, relapse prevention planning, thought records | CBT works primarily at the cognitive-verbal level. Gestalt therapy works at the experiential-embodied level. Potentially complementary for clients where cognitive approaches engage but somatic and relational dimensions are unaddressed |
| IPSRT | Good evidence for episode prevention. Frank et al. (2005) 2-year RCT: IPSRT in acute phase extended survival without new episode (p = .01). Social rhythm regularity specifically associated with reduced recurrence | Stabilising daily routines (circadian regulation), interpersonal problem-solving, grief for the lost healthy self, medication adherence | IPSRT's interpersonal focus and grief work overlap with Gestalt therapy's relational and phenomenological capacities. IPSRT is more structured and more specifically targeted at the biological rhythm vulnerability of bipolar disorder |
| Family-Focused Therapy (FFT) | Significant reduction in depressive and manic symptoms (SMD −0.38 depression, −0.45 mania in Mandal Basak et al., 2025). Strong effect on relapse rates and family engagement | Psychoeducation for family, communication enhancement, problem-solving skills | FFT addresses the relational system around the person with bipolar disorder. Gestalt therapy works primarily in individual therapeutic encounter but shares FFT's recognition of the relational field as clinically central |
| Gestalt Therapy | No RCT evidence specifically for bipolar disorder. Evidence for Gestalt therapy generally exists for depression and anxiety. Theoretical and clinical rationale for adjunctive contribution | Present-moment awareness, embodied attention, genuine dialogical encounter, contact work, phenomenological inquiry | Reference modality for this article. Positioned as a potential complement to evidence-based approaches, not a replacement |
What the Evidence Supports — and Does Not Support
What the evidence supports for psychotherapy in bipolar disorder: Adjunctive psychosocial interventions combined with pharmacotherapy reduce relapse rates by approximately 40% compared to pharmacotherapy alone (Scott et al., 2007). Group and family psychoeducation show the strongest evidence for relapse prevention. CBT shows moderate evidence for reducing depressive symptoms and relapse rates. IPSRT specifically addresses the circadian rhythm vulnerability and social functioning dimensions of bipolar disorder with good evidence. Family-focused therapy reduces symptoms and relapse rates with meaningful effect sizes. These effects are most reliably demonstrated in patients who are euthymic at the start of treatment and in those with fewer prior episodes.
What the evidence does not support: Any psychotherapy as a replacement for pharmacotherapy in bipolar disorder, particularly for Bipolar I. Psychotherapy initiated during acute manic episodes. Gestalt therapy or any experiential approach as a primary treatment for bipolar disorder. Mindfulness-based interventions showing controlled-comparison evidence comparable to their within-group pre-post effects.
What the evidence says about Gestalt therapy specifically: Nothing specific — no controlled studies of Gestalt therapy for bipolar disorder exist. The Raffagnino (2019) systematic review of Gestalt therapy's evidence base, covering 11 peer-reviewed studies, found positive outcomes for depression and group-based presentations but did not include bipolar disorder-specific studies. Extrapolating from general Gestalt therapy evidence to specific claims about its effectiveness for bipolar disorder would be evidentially unwarranted. For the full account, see our article on Gestalt Therapy Research and Evidence Base.
Strengths, Limitations, and Misunderstandings
Potential Strengths of Gestalt Therapy for People with Bipolar Disorder
Within an appropriate treatment framework, Gestalt therapy may offer genuine strengths: the cultivation of present-moment somatic awareness that may support early warning sign recognition; genuine phenomenological attention to the lived experience of this specific person's bipolar disorder rather than generic disorder management; a relational presence that remains consistent and genuine across mood states; and an experiential framework for working with the grief, shame, and identity challenges that chronic bipolar disorder frequently generates. For people who have engaged with more structured, skills-based approaches and find them useful but insufficient, Gestalt therapy's experiential depth may address dimensions that protocol-based approaches do not primarily target.
Important Limitations and Misunderstandings
Gestalt therapy is not evidence-based for bipolar disorder. This distinction is fundamental and must be communicated clearly to clients. Informed consent requires that clients understand what the evidence base for their treatment actually is, and what is being offered on the basis of clinical reasoning rather than controlled trial evidence.
Gestalt therapy does not address the biological vulnerability of bipolar disorder. The circadian rhythm dysregulation, the genetic vulnerability, and the neurobiological underpinnings of bipolar disorder are not targets of Gestalt therapy. Treating Gestalt therapy as comprehensive bipolar disorder treatment would be clinically irresponsible.
Not all clients are suitable for Gestalt therapy at all points in the illness course. Acute mania, active psychosis, severe cognitive impairment, and acute suicidal crisis are all contraindications for the intensive experiential work that Gestalt therapy involves. Clinical judgment about timing and appropriate therapeutic intensity is essential.
Therapist competence requirements. Working with bipolar disorder requires specific knowledge of the condition, its treatment, the warning signs of mood escalation, and the appropriate clinical response when these occur. Gestalt therapists working with this population without this knowledge are practising outside their competence. Supervision with someone who has expertise in mood disorders is advisable.
Gestalt therapy does not address medication adherence directly. Medication adherence is one of the most important modifiable risk factors for relapse in bipolar disorder. Gestalt therapy's relational depth may support a more meaningful relationship to the treatment decision — but clinicians should not assume that this addresses the structured adherence support that research-backed interventions specifically provide.
Questions Clinicians Commonly Ask About Gestalt Therapy and Bipolar Disorder
The following questions reflect the genuine clinical uncertainties that arise when Gestalt therapists encounter clients with bipolar disorder — or when non-Gestalt clinicians consider whether to refer to a Gestalt practitioner. The answers are grounded in the evidence presented throughout this article and in the clinical and ethical principles that responsible practice requires.
Full mania is a contraindication for intensive experiential work. The elevated arousal, disinhibition, boundary loosening, and — in severe cases — psychotic features that characterise mania actively undermine the conditions Gestalt therapy requires: grounded somatic attention, present-moment phenomenological focus, and sufficient self-observer capacity to engage with the contact process. Attempting experiential expansion of awareness or emotional expression during mania risks amplifying rather than containing the episode.
The appropriate clinical response during acute mania is to shift the session's character substantially — from experiential exploration toward supportive containment — and to ensure immediate contact with the psychiatric team. If the client requires hospitalisation, individual outpatient therapy is typically suspended until stability is re-established. Attempting to maintain the ordinary therapeutic frame during acute mania is not consistent with either Gestalt ethics (genuine care for the client's wellbeing) or sound psychiatric practice.
⚠ Clinical priority during mania: safety → psychiatric liaison → supportive containment → resume therapeutic work when euthymicYes, clinically meaningfully so. Hypomania, by definition, does not involve the severe functional impairment or the psychotic features of mania, and the client typically retains self-observer capacity. Sessions can usually continue, but require significant adjustment. Specifically: avoid experiential work that invites further arousal, expansiveness, or boundary-dissolution (some chairwork, energy-amplification experiments, or deep emotional activation fall into this category). Instead, prioritise grounding, somatic settling, and present-moment attentiveness to what is actually happening in the client's body and mind.
The specific clinical tasks during hypomania are: early recognition of the elevated state, monitoring for escalation toward mania, ensuring the psychiatric team is informed, and — critically — not colluding with the client's enjoyment of the hypomanic state by treating it as therapeutic progress. The hypomanic state often presents as heightened insight and creativity; the therapist needs to hold clearly that this is an episode, not the client at their best.
Several Gestalt techniques carry specific cautions in this population:
- Chairwork and empty-chair work during elevated states. These techniques can rapidly intensify emotional arousal and expand the felt sense of possibility — both of which are contraindicated during hypomania or mania. Chairwork is most appropriate during euthymic periods when the client has sufficient grounding to engage with intense material without destabilisation.
- Energy amplification experiments. Any experiment that invites the client to increase the intensity or volume of expression — "say that louder," "let that feeling really come" — requires caution in a population prone to elevated arousal states. The question to hold is always: am I supporting genuine contact with present experience, or am I amplifying a state that may already be trending elevated?
- Deep body awareness work during depressive episodes. Inviting a severely depressed client to deepen their somatic attention may intensify contact with suffering to a degree that is not helpful and that could increase distress or suicidal ideation. Body awareness work during depression should be gentle, paced, and always in service of some quality of companionship rather than intensification.
- Dream work and imagery work. These approaches can access material rapidly and with intensity. During any elevated or vulnerable state, they should be used with caution — the material that emerges may exceed the client's current regulatory capacity.
- Experiments that challenge contact boundaries. For clients with a history of manic episodes involving impulsive or disinhibited behaviour, experiments that invite boundary-loosening or spontaneous expression need careful framing and sufficient therapeutic context to prevent generalisation outside the session.
The core guidelines for bipolar disorder psychotherapy — across NICE, APA, CANMAT, and BAP — emphasise: medication adherence, psychoeducation, relapse prevention, early warning sign recognition, and lifestyle regularity. Gestalt therapy does not provide any of these in the structured, manualised form that the evidence supports. The appropriate integration model is therefore complementary rather than substitutive.
In practice, this means:
- Ensure the client is engaged with appropriate psychiatric care and, where indicated, with evidence-based adjunctive interventions (psychoeducation, IPSRT, CBT for relapse prevention).
- Position Gestalt work as addressing the experiential, relational, and phenomenological dimensions that these approaches do not primarily target — the lived quality of the illness, the interpersonal aftermath of episodes, the grief and identity work, the present-moment somatic awareness that may deepen early warning sign recognition.
- Use the Gestalt framework's emphasis on awareness to support — not replace — the structured mood monitoring and warning sign identification that psychoeducation teaches.
- Be explicit with clients about what Gestalt therapy can and cannot offer for bipolar disorder, and ensure informed consent reflects this clearly.
Coordination with psychiatric services is not optional — it is an ethical requirement of working with bipolar disorder. At a minimum, the Gestalt therapist should:
- Obtain appropriate consent to share information with the psychiatrist and establish a clear protocol for when and how communication will occur.
- Maintain awareness of the client's current medication regimen — not to prescribe or advise, but to understand the clinical context. Significant medication changes can affect mood, energy, and the client's availability for experiential work.
- Have a clear escalation plan. Before beginning work with a client with bipolar disorder, establish what will happen if the client presents with signs of a manic episode, if suicidal ideation emerges, or if there are other clinical emergencies. This plan should be documented and known to the client.
- Communicate proactively, not only in crisis. Brief regular contact with the treating psychiatrist — with the client's consent — supports coordinated care and prevents the fragmentation that can occur when a client's different clinicians are unaware of each other's work.
- Know your limits. Bipolar disorder carries elevated suicide risk. If the client presents with acute suicidal ideation during a depressive episode, the appropriate response is risk assessment and psychiatric liaison, not continued experiential therapy. Understanding when to step back from the Gestalt framework and into a safety-first clinical mode is not a failure of the approach — it is its ethical expression.
This is one of the most challenging clinical situations that arises in work with bipolar disorder, and it requires careful calibration. Medication resistance and nonadherence are common in bipolar disorder — particularly in relation to hypomanic states that clients may experience as their "true" or "best" selves — and they are significant risk factors for relapse.
The Gestalt therapist's role is not to prescribe, advise, or adjudicate medication decisions — those are properly the psychiatrist's domain. But neither is it to collude uncritically with decisions that carry serious clinical risk. The appropriate Gestalt response is phenomenological: genuine curiosity about the client's actual experience of their medication — its effects, its side effects, what it means to them to take it and what it means to consider stopping — without either moralising or validating.
What this looks like clinically: explore the ambivalence fully, support the client to have a fully informed conversation with their psychiatrist about their concerns, and ensure that the decision — whatever it is — is made as an aware, informed choice rather than an impulsive one. If the client decides to stop medication against medical advice, the appropriate response is to ensure they are doing so with full awareness of the risks and with a clear safety plan — not to support or oppose the decision, but to ensure the client is as aware as possible of what they are choosing and why.
The timing question is clinically significant. The research on adjunctive psychotherapy for bipolar disorder consistently shows better outcomes when treatment is initiated during a euthymic (stable) period rather than during an acute episode — and when the client has fewer prior episodes rather than many (Scott et al., 2007 specifically found diminishing benefit beyond 12 prior episodes).
For a client who has just received a diagnosis, the immediate priorities are typically: psychiatric stabilisation if needed, engagement with psychoeducation (the most evidence-supported early intervention), and establishing a medication regimen. The existential, relational, and phenomenological work that Gestalt therapy is best placed to offer — processing the meaning of the diagnosis, the grief for the pre-illness self, the identity implications of chronic illness, the interpersonal aftermath of past episodes — becomes most available once some degree of stability has been established.
This does not mean Gestalt therapy is inappropriate early in the treatment journey. A newly diagnosed person may specifically benefit from genuine phenomenological companionship with the shock and disorientation of diagnosis. But the depth and intensity of experiential work should be calibrated to where the person is in their illness course and their current mood stability — and should always be coordinated with their broader treatment plan.
Future Research
The most important research gap is the complete absence of controlled studies examining Gestalt therapy for bipolar disorder. Case study and qualitative research — documenting the lived experience of people receiving Gestalt therapy alongside psychiatric treatment for bipolar disorder — would be a meaningful first step toward building an evidence base, even before feasibility studies and trials are possible.
More broadly, the field would benefit from research examining whether the awareness cultivation, phenomenological inquiry, and relational depth of experiential approaches add value beyond structured, protocol-based interventions for the inter-episode period — specifically addressing the dimensions of functioning that remain impaired even after mood stabilisation is achieved. This is where Gestalt therapy's distinctive contributions are most theoretically plausible and where an evidence base is most needed.
Conclusion
Bipolar disorder is a complex, chronic condition whose treatment requires sustained, multidisciplinary care coordinated around the specific needs and circumstances of each person who lives with it. The evidence base for adjunctive psychosocial interventions — particularly psychoeducation in group or family formats, CBT, IPSRT, and family-focused therapy — is substantial, meaningful, and well-established in reducing relapse rates and improving outcomes when combined with appropriate pharmacological management.
Gestalt therapy has no specific evidence base for bipolar disorder and must not be positioned as a primary or standalone treatment. What it may offer, within a well-coordinated treatment context that includes appropriate psychiatric care, is an experiential, phenomenological, and relational framework that addresses dimensions of living with bipolar disorder — present-moment awareness, embodied somatic attentiveness, genuine relational contact, and the phenomenological depth of the lived experience of this specific illness — that structured protocol-based approaches are not primarily designed to reach.
Clinicians who work with people with bipolar disorder within a Gestalt framework have a responsibility to be transparent about what the evidence does and does not support, to work within their clinical competence, to maintain appropriate liaison with psychiatric services, and to understand the psychiatric dimensions of the condition well enough to recognise when the work needs to shift from experiential depth to psychiatric urgency. Within those boundaries, Gestalt therapy's genuine clinical contributions — to awareness, to relationship, to the phenomenological dignity of attending to each person's actual lived experience — can be genuinely valuable for people navigating one of psychiatry's most demanding long-term conditions.
For the broader context of how Gestalt therapy approaches clinical presentations, see our articles on Gestalt Therapy: An Overview and Applications of Gestalt Therapy.
